TITLE:
Study In Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy

CONDITION:
Irritable Colon

INTERVENTION:
alosetron

SUMMARY:

      The purpose of this study is to compare the safety and effectiveness of as needed versus
      fixed dosing of an investigational medication for women with severe diarrhea-predominant
      Irritable Bowel Syndrome (IBS) who have failed conventional therapy.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: Female
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Diagnosed with severe diarrhea-predominant Irritable Bowel Syndrome (IBS).

          -  Failed conventional therapy.

          -  Willing to make daily calls on a touch-tone telephone.

        Exclusion criteria:

          -  History of or current chronic or severe constipation.

          -  Bloody diarrhea, abdominal pain with rectal bleeding.

          -  Thrombophlebitis.

          -  Abnormal thyroid stimulating hormone (TSH) value.

          -  Alcohol and/or substance abuse within past two years.

          -  Pregnant or lactating.

          -  History/treatment of malignancy within past five years.
      
